Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/65007
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCosti, J.en
dc.contributor.authorFreeman, B.en
dc.contributor.authorElliott, D.en
dc.date.issued2011en
dc.identifier.citationExpert Review of Medical Devices, 2011; 8(3):357-376en
dc.identifier.issn1743-4440en
dc.identifier.issn1745-2422en
dc.identifier.urihttp://hdl.handle.net/2440/65007-
dc.description.abstractIntervertebral disc biodevices that employ motion-preservation strategies (e.g., nucleus replacement, total disc replacement and posterior stabilization devices) are currently in use or in development. However, their long-term performance is unknown and only a small number of randomized controlled trials have been conducted. In this article, we discuss the following biodevices: interbody cages, nuclear pulposus replacements, total disc replacements and posterior dynamic stabilization devices, as well as future biological treatments. These biodevices restore some function to the motion segment; however, contrary to expectations, the risk of adjacent-level degeneration does not appear to have been reduced. The short-term challenge is to replicate the complex biomechanical function of the motion segment (e.g., biphasic, viscoelastic behavior and nonlinearity) to improve the quality of motion and minimize adjacent level problems, while ensuring biodevice longevity for the younger, more active patient. Biological strategies for regeneration and repair of disc tissue are being developed and these offer exciting opportunities (and challenges) for the longer term. Responsible introduction and rigorous assessment of these new technologies are required. In this article, we will describe the properties of the disc, explore biodevices currently in use for the surgical treatment of low back pain (with an emphasis on lumbar total disc replacement) and discuss future directions for biological treatments. Finally, we will assess the challenges ahead for the next generation of biodevices designed to replace the disc.en
dc.description.statementofresponsibilityJohn J Costi, Brian JC Freeman, Dawn M Elliotten
dc.language.isoenen
dc.publisherExpert Reviews Ltden
dc.rightsCopyright status unknownen
dc.subjectbiocompatibility; biomaterials; biomechanics; current; disc replacement; future; interbody cages; intervertebral disc; spine; tissue engineeringen
dc.titleIntervertebral disc properties: challenges for biodevicesen
dc.typeJournal articleen
dc.identifier.rmid0020108867en
dc.identifier.doi10.1586/ERD.11.1en
dc.identifier.pubid29632-
pubs.library.collectionOrthopaedics and Trauma publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidFreeman, B. [0000-0003-0237-9707]en
Appears in Collections:Orthopaedics and Trauma publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.